Monthly Archives: July 2012

More Than Half of Biotech Venture Financings Are Early Stage Deals
July 26, 2012

Most readers won’t believe the title, or at least not if they’ve read much in the past few years about the anemic early stage biotech environment.  But hopefully this post will convince them. It all comes down to what do


Where Is Everyone? Biotech’s Dwindling Number of Venture Firms
July 24, 2012

The past few weeks have been full of bad news about biotech venture: the numbers were abysmal as venture investments into biotech during the first half of 2012 were off some 40% from last year.  This drop can’t be a


Venture Debt: Under-Appreciated Tool for Building Biotechs
July 11, 2012

Cash-burning R&D-stage biotechs have big appetites for cash, which is typically addressed with an equity-based diet.  It’s also supported through corporate partnerships and other less dilutive means such as grants and foundation funding.  But another important and often under-appreciated source